200 related articles for article (PubMed ID: 23890079)
1. Inhibition of transketolase by oxythiamine altered dynamics of protein signals in pancreatic cancer cells.
Wang J; Zhang X; Ma D; Lee WP; Xiao J; Zhao Y; Go VL; Wang Q; Yen Y; Recker R; Xiao GG
Exp Hematol Oncol; 2013; 2():18. PubMed ID: 23890079
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of protein phosphorylation in MIA pancreatic cancer cells: confluence of metabolic and signaling pathways.
Zhang H; Cao R; Lee WN; Deng C; Zhao Y; Lappe J; Recker R; Yen Y; Wang Q; Tsai MY; Go VL; Xiao GG
J Proteome Res; 2010 Feb; 9(2):980-9. PubMed ID: 20035555
[TBL] [Abstract][Full Text] [Related]
3. Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation.
Boros LG; Puigjaner J; Cascante M; Lee WN; Brandes JL; Bassilian S; Yusuf FI; Williams RD; Muscarella P; Melvin WS; Schirmer WJ
Cancer Res; 1997 Oct; 57(19):4242-8. PubMed ID: 9331084
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of glycogen phosphorylation induces changes in cellular proteome and signaling pathways in MIA pancreatic cancer cells.
Ma D; Wang J; Zhao Y; Lee WN; Xiao J; Go VL; Wang Q; Recker RR; Xiao GG
Pancreas; 2012 Apr; 41(3):397-408. PubMed ID: 22158071
[TBL] [Abstract][Full Text] [Related]
5. Oxythiamine and dehydroepiandrosterone induce a G1 phase cycle arrest in Ehrlich's tumor cells through inhibition of the pentose cycle.
Raïs B; Comin B; Puigjaner J; Brandes JL; Creppy E; Saboureau D; Ennamany R; Lee WN; Boros LG; Cascante M
FEBS Lett; 1999 Jul; 456(1):113-8. PubMed ID: 10452541
[TBL] [Abstract][Full Text] [Related]
6. Dual effects for lovastatin in anaplastic thyroid cancer: the pivotal effect of transketolase (TKT) on lovastatin and tumor proliferation.
Wang CY; Shui HA; Chang TC
J Investig Med; 2018 Jun; 66(5):1-9. PubMed ID: 29502067
[TBL] [Abstract][Full Text] [Related]
7. Mechanical insights of oxythiamine compound as potent inhibitor for human transketolase-like protein 1 (TKTL1 protein).
Mariadasse R; Biswal J; Jayaprakash P; Rao GR; Choubey SK; Rajendran S; Jeyakanthan J
J Recept Signal Transduct Res; 2016; 36(3):233-42. PubMed ID: 26481897
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Consequences of LDHA inhibition by Epigallocatechin Gallate and Oxamate in MIA PaCa-2 Pancreatic Cancer Cells.
Lu QY; Zhang L; Yee JK; Go VW; Lee WN
Metabolomics; 2015 Feb; 11(1):71-80. PubMed ID: 26246802
[TBL] [Abstract][Full Text] [Related]
9. Synergistic Anticancer Effects of Gemcitabine with Pitavastatin on Pancreatic Cancer Cell Line MIA PaCa-2 in vitro and in vivo.
Chen YH; Chen YC; Lin CC; Hsieh YP; Hsu CS; Hsieh MC
Cancer Manag Res; 2020; 12():4645-4665. PubMed ID: 32606957
[TBL] [Abstract][Full Text] [Related]
10. Profiling pancreatic cancer-secreted proteome using 15N amino acids and serum-free media.
Xiao J; Lee WN; Zhao Y; Cao R; Go VL; Recker RR; Wang Q; Xiao GG
Pancreas; 2010 Jan; 39(1):e17-23. PubMed ID: 19904223
[TBL] [Abstract][Full Text] [Related]
11. [MiR-150-5p inhibits the proliferation and promoted apoptosis of pancreatic cancer cells].
Sun Y; Jin XL; Zhang TT; Jia CW; Chen J
Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):460-4. PubMed ID: 24246865
[TBL] [Abstract][Full Text] [Related]
12. A dose- and time-dependent effect of oxythiamine on cell growth inhibition in non-small cell lung cancer.
Bai L; Zhu HL
Cogn Neurodyn; 2022 Jun; 16(3):633-641. PubMed ID: 35603057
[TBL] [Abstract][Full Text] [Related]
13. The in vitro and in vivo anti-metastatic efficacy of oxythiamine and the possible mechanisms of action.
Yang CM; Liu YZ; Liao JW; Hu ML
Clin Exp Metastasis; 2010 May; 27(5):341-9. PubMed ID: 20449639
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus type 16 E6 promotes cervical cancer proliferation by upregulating transketolase enzymatic activity through the activation of protein kinase B.
Hao S; Meng Q; Sun H; Yang X; Liu B; Zhang Y; Zhou H; Xu Z; Wang Y
Mol Carcinog; 2024 Feb; 63(2):339-355. PubMed ID: 37988232
[TBL] [Abstract][Full Text] [Related]
15. Claudin 7 as a possible novel molecular target for the treatment of pancreatic cancer.
Okui N; Kamata Y; Sagawa Y; Kuhara A; Hayashi K; Uwagawa T; Homma S; Yanaga K
Pancreatology; 2019 Jan; 19(1):88-96. PubMed ID: 30416041
[TBL] [Abstract][Full Text] [Related]
16. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
Alcock RA; Dey S; Chendil D; Inayat MS; Mohiuddin M; Hartman G; Chatfield LK; Gallicchio VS; Ahmed MM
Oncogene; 2002 Nov; 21(51):7883-90. PubMed ID: 12420225
[TBL] [Abstract][Full Text] [Related]
17. Effect of oxythiamine on adrenal thiamine pyrophosphate-dependent enzyme activities.
Strumilo SA; Senkevich SB; Vinogradov VV
Biomed Biochim Acta; 1984; 43(2):159-63. PubMed ID: 6732754
[TBL] [Abstract][Full Text] [Related]
18. Posttranslational Acylations of the Rat Brain Transketolase Discriminate the Enzyme Responses to Inhibitors of ThDP-Dependent Enzymes or Thiamine Transport.
Aleshin VA; Kaehne T; Maslova MV; Graf AV; Bunik VI
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255994
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the oxidative and nonoxidative pentose phosphate pathways by somatostatin: a possible mechanism of antitumor action.
Boros LG; Brandes JL; Yusuf FI; Cascante M; Williams RD; Schirmer WJ
Med Hypotheses; 1998 Jun; 50(6):501-6. PubMed ID: 9710324
[TBL] [Abstract][Full Text] [Related]
20. Diverse mechanisms of growth inhibition by luteolin, resveratrol, and quercetin in MIA PaCa-2 cells: a comparative glucose tracer study with the fatty acid synthase inhibitor C75.
Harris DM; Li L; Chen M; Lagunero FT; Go VL; Boros LG
Metabolomics; 2012 Apr; 8(2):201-210. PubMed ID: 22754424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
